Skip to content

Study of normal saline versus plasmalyte as resuscitation fluid in septic shock

A Randomized Controlled Trial of Normal Saline Versus Plasmalyte as Resuscitation Fluid in Children With Septic Shock - SPaRSh

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/11/007472
Enrollment
60
Registered
2016-11-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Septic shock

Interventions

Intervention1: Normal Saline: 20 mL/Kg intravenous, frequency is decided by the clinical response. Control Intervention1: Plasmalyte: 20 mL/Kg, intrvenous Frequency is decided by the clinical response

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children presenting to pediatric emergency with septic shock requiring fluid boluses will be enrolled into the study. Septic shock will be defined as sepsis and hypotension as systolic blood pressure less than 70 mm Hg in infant and less than 70 plus age times two after 1 year of age or three of the following four clinical signs: viz o decreased pulse volume o capillary filling time more than or equal to 3 sec o tachycardia as per age appropriate norms and o urine output less than 1 mL/kg/hr or less than 20 mL/hr in 20 kg or above child

Exclusion criteria

Exclusion criteria: Children with preexisting/ established renal disease, Children with underlying liver disorders, Children with preexisting cardiac diseases, Children with raised ICP,Children with hyperkalemia, Children who had received fluid boluses outside

Design outcomes

Primary

MeasureTime frame
Increase in serum creatinine levels from baseline to peakTimepoint: At 24 hours

Secondary

MeasureTime frame
Proportion of children requiring RRTTimepoint: during hospital stay;Proportion of in hospital mortalityTimepoint: during hospital stay;Proportion of patients developing new/progressive AKI (defined by change in creatinine as per KDIGO)Timepoint: during hospital stay;Time to different events (e.g. AKI, Metabolic acidosis, death etc.)Timepoint: during hospital stay;Change in chloride levels, pH and bicarbonate levels (baseline to 24 hrs.)Timepoint: 24 hours;Changes in the base excessTimepoint: 24 hours;Length of ICU / hospital stayTimepoint: during hospital stay;Length of MVTimepoint: during hospital stay;Proportion of children requiring mechanical ventilationTimepoint: during hospital stay

Countries

India

Contacts

Public ContactM Jayashree

PGIMER

mjshree@hotmail.com09815594343

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026